Table 1.
Baseline characteristics of study participants by long COVID‐19 status.
| No long COVID (N = 62) | Long COVID (N = 32) | p Value | |
|---|---|---|---|
| Age (years) | 49 (42–57) | 52 (45.5–59) | .32 |
| Males | 41.9% | 34.4% | .51 |
| BMI (kg/m2) | 29.1 (24.7–33.1) | 26.2 (25.7–29.4) | .45 |
| HIV positivea | 20/57 (35.1%) | 56.3% | .05 |
| HIV viral load (copies/mL) | 0 (0–0) | 0 (0–0) | .64 |
| CD4 count (cells/µL) | 622 (346–827) | 492 (181–699) | .17 |
| Hypertensive | 41.9% | 31.3% | .31 |
| Diabetic | 8.1% | 0% | .10 |
| Hospitalized for COVID‐19 | 58.1% | 46.9% | .30 |
| Fully vaccinated for COVID‐19 | 69.4% | 50% | .07 |
Note: CD4 counts and HIV viral loads are only compared between the HIV+ individuals in the two groups.
Abbreviations: COVID‐19, coronavirus disease 2019; HIV, human immunodeficiency virus.
a
Excludes five individuals with diabetes in the long COVID group.